Insmed | Ativo Circulante



Current Assets Alterar Data
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Cytokinetics USD 956.05M 151.89M 2025-03
DBV Technologies USD 68.76M 21.2M 2024-09
Dynavax Technologies USD 815.97M 32.97M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Insmed USD 1.4B 218.97M 2025-03
Novartis USD 29.7B 1.56B 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Insmed Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.